Drug Development and Precision Medicine

Instead of the traditional “one-size-fits-all” healthcare, we believe patients should be treated differently based on their genetic background. At the Center for Stem Cell & Organoid Medicine (CuSTOM), we are enthusiastic about the opportunity to customize therapeutic strategy for each patient, by assessing the drug efficacy and toxicity in patient-specific iPSC derived cells and organoids. The newly formed CuSTOM Accelerator will facilitate high-throughput drug screening and bench-to-bedside translation of stem cell technology through academic-industrial partnerships, licensing agreements, and the creation of startups.

Reference:

CuSTOM Accelerator: Our technology